tradingkey.logo
tradingkey.logo
Search

Eloxx Pharmaceuticals Ord Shs

ELOX
Add to Watchlist
12.000USD
-0.210-1.72%
Close 06/24, 16:00ETQuotes delayed by 15 min
49.28MMarket Cap
--P/E TTM
You can find the annual or quarterly income statement of Eloxx Pharmaceuticals Ord Shs here for insights into the performance and operational efficiency of Eloxx Pharmaceuticals Ord Shs.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
Operating expenses
--3.79M
R&D expenses
--1.66M
Operating profit
---3.79M
Net non-operating interest income (expenses)
Non-operating interest income
--23.00K
Non-operating interest expense
--29.00K
Special income (expenses)
--56.00K
Other non-operating income (expenses)
---9.00K
Income before tax
---3.75M
Income after tax
---3.75M
Net income from continuous operations
---3.75M
Net income attributable to controlling interests
---3.75M
Net income attributable to common shareholders
---3.75M
Basic earnings per share
---0.86
Diluted earnings per share
---0.86
Dividend per share
--0.00
Currency unit
USD
Audit opinions
--

FAQs

What is the income statement?

The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.
KeyAI